Treatment for rheumatoid arthritis in 2017

A review article summarizes the current approaches to the treatment for rheumatoid arthritis (RA) according to Treat-toTarget strategy, including glucocorticoids, disease modifying anti-rheumatic drugs, particularly metothrexate, and biologic agents with different mechanisms of action. The objectives of treatment are to achieve and sustain complete remission in patients with early RA and/or low disease activity in patients with advanced RA, to improve functional activity and healthrelated quality of life and to reduce the risk of early mortality.

Key words

Rheumatoid arthritis, treatment, glucocorticoids, metothrexate, biologic agents.